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应用RESS技术以 60µm喷嘴在 20MPa、60℃下制得CoQ10质量含量为 1%的
































CoQ10 as a lipid soluble compound has wide applications in pharmaceutical, food, 
and cosmetic industries. Yet, CoQ10 has some evident problems when it is used, such as 
relatively large particle size, insolubility in water, and low bioavailability. Solid lipid 
nanoparticles (SLN) represent a kind of nano-drug carrier with a lot of advantages. Over 
the past couple of years, important insights into the manufacturing of micro- and 
nano-particles by supercritical fluid technology have been achieved. The objective of this 
study is to produce CoQ10 nanoparticles and CoQ10 SLN by supercritical fluid 
technology.  
The RESS process was employed to produce myristic acid nanoparticles with an 
average size of 210 nm and CoQ10 nanoparticles with an average size of 1.9µm (Sauter 
diameter 330 nm) at 20MPa, 60oC with a 60 µm-size nozzle. Results show that the 
myristic acid particle size decreases and the particle size distribution (PSD) narrows with 
the increase of the pre-expansion pressure; increasing the pre-expansion temperature 
could decrease the size of the myristic acid particles. In the case of CoQ10, the particle 
size decreases with the increase of the pre-expansion pressure; the Sauter diameter 
decreases with the increase of the pre-expansion temperature.  
The RESS process was also employed to produce CoQ10SLN powders with size of 
170 nm（20MPa，60℃，60 µm-size nozzle）and the CoQ10 content of 1% (mass). When 
the CoQ10SLN is dissolved in water with a concentration of 0.001g/ml, the solution’s pH 
is 4.81 and the Zeta potential is -26.49mV at 13℃, indicating a high stability of the SLN. 
DSC study shows that the melting point of the SLN decreases obviously compared to 
that of the physical mixture of myristic acid and CoQ10, and XRD patterns show that 
CoQ10 is efficiently fused in myristic acid. 
The PGSS process was employed to produce CoQ10/PEG (polyethylene glycol 
6000) composite particles. Solid CoQ10 nanoparticles with an average size of 190 nm 
were obtained by separating the composite partcles（obtaied at 25MPa，80℃, melt 
solution flowrate of 1.0ml/min, CoQ10 mass fraction of 40% with a100 µm-size nozzle）. 















process, the particle size of dispersed CoQ10 decreases with the increasing of the 
pre-expansion pressure or the pre-expansion temperature. On the other hand, the particle 
size increases with the increase of the CoQ10/PEG solution flow rate or the content of 
CoQ10. 
The PGSS process was also employed to produce CoQ10/PEG/myristic acid 
composite particles. Following the separation of the composite particles obatined at 
20MPa，75℃, melt solution flowrate of 1.0ml/min, the CoQ10/myristic acid mass fraction 
of 95% with a 100 µm-size nozzle, CoQ10SLN powders with an average size of 560 nm 
were obatined. When the CoQ10SLN is dissolved in water with a concentration of 
0.001g/ml, the solution’s pH is 4.88 and the Zeta potential is -28.8mV at 20℃, indicating 
a high stability of the SLN. DSC study shows that the melting point of the SLN decreases 
compared to that of the physical mixture of myristic acid and CoQ10, and XRD patterns 
show that CoQ10 is efficiently encapsulated in myristic acid. 
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CoQ10（Coenzyme ubquinone, CoQ10, 辅酶Q10或Q10）又称癸烯醌、泛醌，化学
名称 2,3-二甲氧基-5-甲基-6-癸异戊烯基苯醌，是一种醌环类化合物。它于1957 年被
发现，1958 年由卡鲁福鲁卡斯博士认定化学结构，其结构类似于维生素K，因其母













图 1-1 CoQ10的化学结构 
Figure 1-1. Chemical structures of CoQ10
 



















表 1-1 CoQ10在SCCO2中的溶解度 







305K 313K 323K 
11.6 1.57 12.1 0.99 9.2 0 
14.1 2.99 15.8 2.78 12.1 0 
17.8 5.21 18.4 4.24 14.2 0.74 
22.2 6.51 21.1 6.62 15.8 1.30 
22.9 6.97 26.2 11.29 18.1 2.51 
25.9 9.91   21.7 4.68 
    25.3 9.56 
*yCoQ10 in molar fraction 
 
表 1-2 CoQ10在CO2中的熔点 
Table 1-2. Melting point of CoQ10 in CO2
Pressure (MPa) Melting point (K) Pressure (MPa) Melting point (K) 
0.1 322.5 7.03 306.3 
0.71 321.5 7.41 305.4 
1.8 319.4 8.93 305.8 
2.84 316 10.45 306.2 
4.16 314.2 12.4 306.3 
5.15 312.7 15 306.7 
5.86 310.3 17.65 306.9 
































































150-160 吨，其中功能食品消费 100 多吨（60%左右）、药品消费 30 多吨（20%左右）、
化妆品消费 10 多吨（8%左右）。到 2005 年全球CoQ10消费量已经突破 300 吨，功
能食品、药品、化妆品三者消费的比例基本保持一致。预计到 2010 年，CoQ10全球
















































































（Supercritical Fluid, SCF）。 
图 1-2 是纯流体的典型压力－温度图。图中线 L1 表示气－固平衡的升华曲线，






















图 1-2 纯流体的压力-温度图 
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